MD Medical Board of Directors recommends dividends for 2025

MD Medical Group (“MD Medical Group”, “MDMG”, "Group" or the "Company"; MOEX: MDMG), a leading Russian private healthcare provider, announces the Board of Directors' decisions including recommendations to shareholders on the amount of dividends for 2025.

At its meeting on May 15, 2026, the Company's Board of Directors resolved to convene the Annual General Meeting of Shareholders on June 25, 2026, preliminarily approved the 2025 annual report, recommended that the General Meeting of Shareholders approve the 2025 consolidated financial statements, the Company's auditor for 2026, and determined a list of candidates for election to the Board of Directors.

The Board of Directors also resolved to recommend to the General Meeting of Shareholders, in addition to the dividends paid for the first six months of 2025, to approve a dividend payment of RUB 3.5 billion, or RUB 47 per ordinary share of MD Medical Group IPJSC (before dividend income tax) for the twelve months of 2025. The Board of Directors proposed setting July 14, 2026, as the date on which persons entitled to receive dividends are determined. Together with already paid dividends for the first six months, total dividends for 2025 are expected to exceed 60% of the Group's consolidated net profit for 2025 under IFRS and amount to RUB 89 per share.

Learn more about the decisions of the Board of Directors following the link.

About MD Medical Group

MD Medical Group is a leading provider in the highly attractive Russian private healthcare service market. Today, the Company manages 90 state-of-the-art healthcare facilities, including 14 multidisciplinary hospitals and 76 out-patient clinics in 35 regions of the Russian Federation. In 2025, MD Medical Group's revenue amounted to RUB 43.5 bln. while EBITDA stood at RUB 13.3 bln. The Company's ordinary shares are traded on Moscow Exchange (MOEX: MDMG).